Arca Space Capital has acquired a 20% stake in Unifarco S.p.A. through a €20 million capital increase to support the company's growth strategy in the dermocosmetic market.

Target Company Overview

Founded in 1982 and based in Belluno, Italy, Unifarco S.p.A. is a leading European player in the field of scientific dermocosmetics. The company operates a unique business model relying on collaboration with over 7,000 independent pharmacies across Italy, Spain, Germany, Austria, France, and Belgium, which includes more than 650 specialized pharmacies that provide personalized advisory services to their customers.

Unifarco's portfolio encompasses a wide array of products, including dermocosmetics, nutraceuticals, functional foods, and makeup. The brand community, Farmacisti Preparatori, stands out as a leader in the pharmacy channel throughout Europe, alongside proprietary specialty brands such as Ceramol, Dolomia, MyCli, Biomalife, Genage, and Keylife. The company anticipates consolidated revenues of approximately €200 million for the year 2025, driven by continuous innovation from a team of over 50 in-house scientific researchers, strong brand equity, and international expansion efforts.

Industry Overview in Italy

The Italian dermocosmetic industry has seen significant growth in recent years, supported by a rising awareness of skin health and the increasing popularity of specialized cosmetic products. Consumers are increasingly seeking high-quality skincare solutions, whic